Tag: Phase 1 Trial

November 20, 2019

Spring Bank Doses Patients in Phase 1 Clinical Trial of SB 11285

The company announced it has started dosing patients in its Phase 1 clinical trial of SB 11295 in patients with...
August 13, 2019

Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103

Mustang Bio (NASDAQ:MBIO) has announced a US$9.28 million grant from the California Institute for Regenerative Medicine (CIRM) to fund an...
April 10, 2019

Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692

Concert Pharmaceuticals (NASDAQ:CNCE) has started an additional trial in the Phase 1 program evaluating CTP-692, a deuterium-modified form of D-serine...
February 11, 2019

Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100

Aduro Biotech (NASAQ:ADRO) has announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 for...
December 3, 2018

Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy

Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced the...
November 19, 2018

Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022

Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced that...
November 15, 2018

Syros Releases Early Clinical Trial Data

This part of the trial was for dose escalation and demonstrated proof-of-mechanism at tolerable doses of the drug. This is...